Government Resource Serious medication errors from intravenous administration of nimodipine oral capsules. Citation Text: United States Food and Drug Administration; FDA. Copy Citation Save Save to your library Print Share Facebook Twitter Linkedin Copy URL August 11, 2010 United States Food and Drug Administration; FDA. This announcement reports on numerous errors in which an oral medication, nimodipine, was administered intravenously and describes how such errors occur. Free full text Related information Save Save to your library Print Share Facebook Twitter Linkedin Copy URL Cite Citation Citation Text: United States Food and Drug Administration; FDA. Copy Citation Related Resources From the Same Author(s) New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients. September 29, 2010 MedWatch E-list. March 6, 2005 FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa (ceftolozane and tazobactam). June 3, 2015 FDA Drug Safety Communication: FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved. January 13, 2016 Teaching Kids About Using Medicine Safely. February 29, 2012 BeSafeRx: Know Your Online Pharmacy. October 10, 2012 Lock it Up: Medicine Safety in Your Home. November 30, 2011 Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors. October 10, 2018 Be an Active Member of Your Health Care Team. May 21, 2014 OpenFDA. June 11, 2014 FDA MedWatch and Patient Safety Tutorial. December 10, 2008 Medicines in My Home. August 2, 2006 Interference between CT and Electronic Medical Devices. July 30, 2008 Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging. March 3, 2010 Shelhigh, Inc. implantable medical devices. May 2, 2007 FDA Pharmacists Help Consumers Use Medicines Safely. November 19, 2014 FDA Patient Safety News. A Video News Show for Health Professionals. March 6, 2005 Promethazine HCl (marketed as Phenergan) Information. May 3, 2006 Benzocaine sprays marketed under different names, including Hurricaine, Topex, and Cetacaine. February 22, 2006 SmartTots. April 13, 2011 Bar Code Label Requirements for Blood and Blood Components. April 26, 2006 Infections associated with reprocessed flexible bronchoscopes. September 30, 2015 FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients. March 11, 2015 Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning. March 4, 2015 Four Medication Safety Tips for Older Adults. June 18, 2014 Important information for the safe use of Tussionex Pennkinetic Extended-Release Suspension. March 26, 2008 Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip). June 22, 2011 Wear face masks with no metal during MRI exams. December 16, 2020 Postmarket Drug Safety Information for Patients and Providers. November 19, 2008 Accidental exposures to fentanyl patches continue to be deadly to children. July 21, 2021 Strategic Plan for Preventing and Mitigating Drug Shortages. November 13, 2013 Use purple bracelets or wristbands only for do not resuscitate status - letter to industry. August 25, 2021 Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health. June 6, 2018 Safety Considerations for Product Design to Minimize Medication Errors: Guidance for Industry. January 9, 2013 Drug Shortages: Root Causes and Potential Solutions. November 13, 2019 FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering. April 17, 2019 A Review of FDA’s Approach to Medical Product Shortages. November 16, 2011 Use duodenoscopes with innovative designs to enhance safety: FDA Safety Communication. May 4, 2022 Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment. March 22, 2006 Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens. April 8, 2009 Maalox Total Relief and Maalox Liquid Products: Medication Use Errors. March 3, 2010 Making Medical Devices Safer at Home. January 9, 2013 Safety Problems With Your Child's Medical Device? July 31, 2013 Nimodipine Capsules (marketed as Nimotop). March 1, 2006 Public Health Notification from FDA: Vail Products Enclosed Bed Systems. December 19, 2007 FDA preliminary public health notification: unpredictable events in medical equipment due to new daylight savings time change. January 9, 2005 FDA 101: How to Use the Consumer Complaint System and MedWatch. June 25, 2008 Relenza (zanamivir) inhalation powder. October 21, 2009 Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology. October 21, 2009 Tamiflu (oseltamivir) for oral suspension: potential medication errors. October 7, 2009 Hydrocodone bitartrate and acetaminophen tablets, phenobarbital tablets by Qualitest: recall—incorrect package labeling. February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose. January 19, 2011 Implantable infusion pumps in the magnetic resonance (MR) environment: FDA safety communication—important safety precautions. January 25, 2017 FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. February 7, 2018 FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor). August 12, 2015 FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safety―emphasizing that accidental exposure to used patches can cause death. October 9, 2013 Important change to heparin container labels to clearly state the total drug strength. December 19, 2012 Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays. November 7, 2012 Kadcyla (ado-trastuzumab emtansine): drug safety communication—potential medication errors resulting from name confusion. May 15, 2013 Hospira Carpuject pre-filled cartridges—drug alert: products may contain more than the intended fill volume. May 30, 2012 FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management. November 28, 2018 FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy. August 20, 2021 Safety considerations to mitigate the risks of misconnections with small-bore connectors intended for enteral applications. March 4, 2015 Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling. May 19, 2021 FDA advises health care professionals and patients about insulin pen packaging and dispensing. October 28, 2020 Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings. February 17, 2021 Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling. February 10, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only. February 3, 2021 Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication. October 20, 2021 Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11. September 1, 2021 Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up. October 19, 2022 Important Warnings and Instructions for Heparin Sodium Injection (Baxter). February 20, 2008 Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors. February 21, 2007 Roxane Laboratories initiates a nationwide voluntary recall of a single manufacturing lot of Azathioprine tablets in the U.S. and Puerto Rico. July 26, 2006 Using ventilator splitters during the COVID-19 pandemic--letter to health care providers. February 17, 2021 FDA public health notification: unretrieved device fragments. January 30, 2008 Safe Use Initiative. November 18, 2009 6 Tips to Avoid Medication Mistakes. July 18, 2007 Quick Tips for Buying Medicines Over the Internet. March 6, 2005 Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death. February 20, 2013 Drug Shortages. April 27, 2011 Reprocessing of Reusable Medical Devices. January 11, 2012 Safety Information on Alaris SE Infusion Pumps. November 15, 2006 MedWatch: The FDA Safety Information and Adverse Event Reporting Program. June 22, 2005 Computerized Prescriber Order Entry Medication Safety (CPOEMS): Uncovering and Learning From Issues and Errors. January 13, 2016 Examples of Medical Device Misconnections. March 8, 2023 FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration. April 8, 2020 FDA/ISMP Safe Medication Management Fellowship Program. February 8, 2023 Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples. October 7, 2021 Potential for false positive results with antigen tests for rapid detection of SARS-CoV-2--letter to clinical laboratory staff and health care providers. November 11, 2020 Questions and Answers on FDA's Adverse Event Reporting System (FAERS). September 17, 2008 An Introduction to the Improved FDA Prescription Drug Labeling. November 1, 2006 Fentanyl transdermal system (marketed as Duragesic) information. July 10, 2015 Human Factors and Medical Devices. March 27, 2005 Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff. October 3, 2022 FDA Funding Available for Research Aimed at Reducing Preventable Harm from Medication November 6, 2019 FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing. February 24, 2022 - February 24, 2022 Medication Safety During the COVID-19 Pandemic: What Have We Learned in the United States. June 23, 2020 My Medicines. July 9, 2014 Bar code label requirement for human drug products and biological products. March 27, 2005 View More Related Resources WebM&M Cases Misconnection Leading to Arterial Thrombosis June 28, 2023 Medication guides: patient medication information. A proposed rule by the Food and Drug Administration. June 28, 2023 Annual Perspective Improving Diagnostic Safety and Quality April 26, 2023 Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up. October 19, 2022 Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors: Guidance for Industry. May 25, 2022 Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication. October 20, 2021 Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples. October 7, 2021 Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11. September 1, 2021 FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy. August 20, 2021 FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing. February 24, 2022 - February 24, 2022 WebM&M Cases An Inadvertent Bolus of Norepinephrine. May 26, 2021 Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling. May 19, 2021 Using ventilator splitters during the COVID-19 pandemic--letter to health care providers. February 17, 2021 FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only. February 3, 2021 Potential for false positive results with antigen tests for rapid detection of SARS-CoV-2--letter to clinical laboratory staff and health care providers. November 11, 2020 FDA advises health care professionals and patients about insulin pen packaging and dispensing. October 28, 2020 Dangerous wrong-route errors with tranexamic acid. September 30, 2020 FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder. August 5, 2020 FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents. July 15, 2020 FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration. April 8, 2020 A safety evaluation of the impact of maternity-orientated human factors training on safety culture in a tertiary maternity unit. June 19, 2019 FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering. April 17, 2019 Inadvertent Administration of an Oral Liquid Medicine into a Vein. April 1, 2019 Exploring the human factors of prescribing errors in paediatric intensive care units. March 27, 2019 Safety enhancements every hospital must consider in wake of another tragic neuromuscular blocker event. January 23, 2019 WebM&M Cases One Bronchoscopy, Two Errors January 1, 2019 FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management. November 28, 2018 Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors. October 10, 2018 FDA Safety Communication: recommendations to reduce surgical fires and related patient injury. June 20, 2018 FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. February 7, 2018 View More See More About The Topic Intensive Care Units Health Care Providers Risk Managers Quality and Safety Professionals Critical Care View More
New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients. September 29, 2010
FDA cautions about dose confusion and medication errors for antibacterial drug Zerbaxa (ceftolozane and tazobactam). June 3, 2015
FDA Drug Safety Communication: FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved. January 13, 2016
Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors. October 10, 2018
Benzocaine sprays marketed under different names, including Hurricaine, Topex, and Cetacaine. February 22, 2006
FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients. March 11, 2015
Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning. March 4, 2015
Important information for the safe use of Tussionex Pennkinetic Extended-Release Suspension. March 26, 2008
Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip). June 22, 2011
Use purple bracelets or wristbands only for do not resuscitate status - letter to industry. August 25, 2021
Safety Considerations for Product Design to Minimize Medication Errors: Guidance for Industry. January 9, 2013
FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering. April 17, 2019
Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens. April 8, 2009
FDA preliminary public health notification: unpredictable events in medical equipment due to new daylight savings time change. January 9, 2005
Potentially fatal errors with GDH-PQQ [glucose dehydrogenase pyrroloquinoline quinone] glucose monitoring technology. October 21, 2009
Hydrocodone bitartrate and acetaminophen tablets, phenobarbital tablets by Qualitest: recall—incorrect package labeling. February 16, 2011
Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication use error—reports of accidental overdose. January 19, 2011
Implantable infusion pumps in the magnetic resonance (MR) environment: FDA safety communication—important safety precautions. January 25, 2017
FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. February 7, 2018
FDA Drug Safety Communication: FDA warns about prescribing and dispensing errors resulting from brand name confusion with antidepressant Brintellix (vortioxetine) and antiplatelet Brilinta (ticagrelor). August 12, 2015
FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safety―emphasizing that accidental exposure to used patches can cause death. October 9, 2013
Important change to heparin container labels to clearly state the total drug strength. December 19, 2012
Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays. November 7, 2012
Kadcyla (ado-trastuzumab emtansine): drug safety communication—potential medication errors resulting from name confusion. May 15, 2013
Hospira Carpuject pre-filled cartridges—drug alert: products may contain more than the intended fill volume. May 30, 2012
FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management. November 28, 2018
FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy. August 20, 2021
Safety considerations to mitigate the risks of misconnections with small-bore connectors intended for enteral applications. March 4, 2015
Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling. May 19, 2021
FDA advises health care professionals and patients about insulin pen packaging and dispensing. October 28, 2020
Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings. February 17, 2021
Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling. February 10, 2021
FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only. February 3, 2021
Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication. October 20, 2021
Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11. September 1, 2021
Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up. October 19, 2022
Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors. February 21, 2007
Roxane Laboratories initiates a nationwide voluntary recall of a single manufacturing lot of Azathioprine tablets in the U.S. and Puerto Rico. July 26, 2006
Using ventilator splitters during the COVID-19 pandemic--letter to health care providers. February 17, 2021
Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death. February 20, 2013
Computerized Prescriber Order Entry Medication Safety (CPOEMS): Uncovering and Learning From Issues and Errors. January 13, 2016
FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration. April 8, 2020
Potential for false positive results with antigen tests for rapid detection of SARS-CoV-2--letter to clinical laboratory staff and health care providers. November 11, 2020
Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff. October 3, 2022
FDA Funding Available for Research Aimed at Reducing Preventable Harm from Medication November 6, 2019
FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing. February 24, 2022 - February 24, 2022
Medication Safety During the COVID-19 Pandemic: What Have We Learned in the United States. June 23, 2020
Medication guides: patient medication information. A proposed rule by the Food and Drug Administration. June 28, 2023
Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up. October 19, 2022
Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors: Guidance for Industry. May 25, 2022
Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication. October 20, 2021
Cardinal Health recalls Argyle UVC insertion tray due to missing instructions for use for the Safety Scalpel N11. September 1, 2021
FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy. August 20, 2021
FDA Safety Communication: flexible bronchoscopes and updated recommendations for reprocessing. February 24, 2022 - February 24, 2022
Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling. May 19, 2021
Using ventilator splitters during the COVID-19 pandemic--letter to health care providers. February 17, 2021
FDA updates vinca alkaloid labeling for preparation in intravenous infusion bags only. February 3, 2021
Potential for false positive results with antigen tests for rapid detection of SARS-CoV-2--letter to clinical laboratory staff and health care providers. November 11, 2020
FDA advises health care professionals and patients about insulin pen packaging and dispensing. October 28, 2020
FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder. August 5, 2020
FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents. July 15, 2020
FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration. April 8, 2020
A safety evaluation of the impact of maternity-orientated human factors training on safety culture in a tertiary maternity unit. June 19, 2019
FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering. April 17, 2019
Safety enhancements every hospital must consider in wake of another tragic neuromuscular blocker event. January 23, 2019
FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management. November 28, 2018
Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors. October 10, 2018
FDA Safety Communication: recommendations to reduce surgical fires and related patient injury. June 20, 2018
FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. February 7, 2018